Back to search

A phase II study of irinotecan (CPT‐11) in patients with advanced squamous cell carcinoma of the cervix

Data up to Jan 2025

Published1998
Citations36
References19

Total Citations Per Year

Abstract

References (19)

Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

1985 • 2,298 citations

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

1966 • 2,159 citations

Cancer statistics, 1996

1996 • 1,807 citations

Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.

1988 • 843 citations

DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in Xenografts

1989 • 645 citations

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

1992 • 443 citations

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors.

1987 • 412 citations

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

1985 • 399 citations

Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.

1972 • 315 citations

Phase I and pharmacokinetic trial of weekly CPT-11.

1993 • 300 citations

Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

1972 • 271 citations

Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo

1988 • 213 citations

DNA Topoisomerases as Anticancer Drug Targets

1990 • 195 citations

Treatment of malignant melanoma with camptothecin (NSC-100880).

1972 • 158 citations

Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.

1997 • 135 citations

Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice

1988 • 87 citations

Topoisomerases: Novel therapeutic targets in cancer chemotherapy

1988 • 40 citations

Interleukin-1 alpha-induced modulation of topoisomerase I activity and DNA damage: implications in the mechanisms of synergy with camptothecins in vitro and in vivo.

1996 • 7 citations

Interferon-alpha potentiates the antiproliferative activity of CPT-11 against human colon cancer xenografts in nude mice.

1996 • 3 citations

Cited By (0)

Loading...
A phase II study of irinotecan (CPT‐11) in patients with advanced squamous cell carcinoma… (1998) – Cancer | Metascience Observatory Explorer